197 related articles for article (PubMed ID: 24134128)
1. Arterial ammonia levels in cirrhosis are determined by systemic and hepatic hemodynamics, and by organ function: a quantitative modelling study.
Noiret L; Baigent S; Jalan R
Liver Int; 2014 Jul; 34(6):e45-55. PubMed ID: 24134128
[TBL] [Abstract][Full Text] [Related]
2. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
Miquel M; Bartolí R; Odena G; Serafín A; Cabré E; Galan A; Barba I; Córdoba J; Planas R
Liver Int; 2010 Aug; 30(7):979-87. PubMed ID: 20492509
[TBL] [Abstract][Full Text] [Related]
3. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins.
Tarantino G; Citro V; Esposito P; Giaquinto S; de Leone A; Milan G; Tripodi FS; Cirillo M; Lobello R
BMC Gastroenterol; 2009 Mar; 9():21. PubMed ID: 19292923
[TBL] [Abstract][Full Text] [Related]
4. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.
Plauth M; Roske AE; Romaniuk P; Roth E; Ziebig R; Lochs H
Gut; 2000 Jun; 46(6):849-55. PubMed ID: 10807899
[TBL] [Abstract][Full Text] [Related]
5. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis.
Olde Damink SW; Jalan R; Deutz NE; Redhead DN; Dejong CH; Hynd P; Jalan RA; Hayes PC; Soeters PB
Hepatology; 2003 Jun; 37(6):1277-85. PubMed ID: 12774005
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic circulation and metabolism in patients with acute liver failure.
Clemmesen O
Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280
[TBL] [Abstract][Full Text] [Related]
7. Ammonia levels and the severity of hepatic encephalopathy.
Qureshi MO; Khokhar N; Shafqat F
J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
[TBL] [Abstract][Full Text] [Related]
9. Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients.
Mpabanzi L; Deutz N; Hayes PC; Dejong CH; Olde Damink SW; Jalan R
Aliment Pharmacol Ther; 2012 Apr; 35(8):921-8. PubMed ID: 22360430
[TBL] [Abstract][Full Text] [Related]
10. Spastic paraparesis associated with portal-systemic venous shunting due to congenital hepatic fibrosis.
Demirci M; Tan E; Elibol B; Gedikoğlu G; Saribaş O
Neurology; 1992 May; 42(5):983-5. PubMed ID: 1579253
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hyperammonemia in liver failure.
Jover-Cobos M; Khetan V; Jalan R
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
[TBL] [Abstract][Full Text] [Related]
12. Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial.
Katayama K; Saito M; Kawaguchi T; Endo R; Sawara K; Nishiguchi S; Kato A; Kohgo H; Suzuki K; Sakaida I; Ueno Y; Habu D; Ito T; Moriwaki H; Suzuki K
Nutrition; 2014; 30(11-12):1409-14. PubMed ID: 25280421
[TBL] [Abstract][Full Text] [Related]
13. Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.
Zervos EE; Goode SE; Rosemurgy AS
Am Surg; 1998 Jan; 64(1):71-5; discussion 75-6. PubMed ID: 9457041
[TBL] [Abstract][Full Text] [Related]
14. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
[TBL] [Abstract][Full Text] [Related]
15. Portosystemic encephalopathy in a patient treated with peritoneal dialysis.
Paraíso V; Francos M; Rodríguez-Berzosa F; Felipe C; López-Valdés E; Martín R; Blázquez J; Chacón C; Fidalgo A; Martín J
Am J Kidney Dis; 2007 Jun; 49(6):854-8. PubMed ID: 17533029
[TBL] [Abstract][Full Text] [Related]
16. The "urea index" as a marker of portal flow direction in cirrhosis of the liver.
Hazenberg HJ; Gips CH
Acta Hepatogastroenterol (Stuttg); 1976 Apr; 23(2):93-100. PubMed ID: 1274521
[TBL] [Abstract][Full Text] [Related]
17. Noncirrhotic hyperammonaemic encephalopathy.
Laish I; Ben Ari Z
Liver Int; 2011 Oct; 31(9):1259-70. PubMed ID: 21745294
[TBL] [Abstract][Full Text] [Related]
18. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Hamato N; Okuma M
Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the interrelationship between tests for hepatic function and haemodynamics of portal blood flow in patients with liver cirrhosis.
Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Uchino H
J Gastroenterol Hepatol; 1989; 4 Suppl 1():282-3. PubMed ID: 2519077
[No Abstract] [Full Text] [Related]
20. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
Bizer LS
Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
